Registry of Lobbyists
Corporation: | Hoffmann-La Roche Limited |
Associated registration: | 952745-64-60 |
Communication date: | 2023-09-26 |
Posted date: | 2023-10-15 |
Designated Public Office Holders who participated in the communication: |
Josee LeBlanc,
Senior Policy Analyst
Health Canada (HC) Daniel MacDonald, Director General, Drugs for Rare Diseases Strategic Policy Branch, Health Canada (HC) Darryl Patterson, Director General Innovation, Science and Economic Development Canada (ISED) Andrew Taylor, Director Health Canada (HC) Ritu Banerjee, Assistant Deputy Minister Director General's Office, Innovation, Science and Economic Development Canada (ISED) Mark Schaan, Assistant Deputy Minister, Strategy & Innovation Policy Sector Innovation, Science and Economic Development Canada (ISED) |
Subject Matter of the communication: | Health |
Responsible Officer who filed this communication report: | BRIGITTE NOLET |
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |